p.141 抽出テキスト

commissurotomy. NHLBI Balloon Valvuloplasty Registry Report on immediate and 30-day follow-up results. Circulation 1992; 85: 448- 461. PMID: 1735143 716. Cohen DJ, Kuntz RE, Gordon SP, et al. Predictors of long-term outcome after percutaneous balloon mitral valvuloplasty. N Engl J Med 1992; 327: 1329-1335. PMID: 1406834 717. Song JK, Song JM, Kang DH, et al. Restenosis and adverse clinical events after successful percutaneous mitral valvuloplasty: immediate post-procedural mitral valve area as an important prognosticator. Eur Heart J 2009; 30: 1254-1262. PMID: 19346230 718. Palacios IF, Sanchez PL, Harrell LC, et al. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation 2002; 105: 1465-1471. PMID: 11914256 719. Reyes VP, Raju BS, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994; 331: 961-967. PMID: 8084354 720. Jaber WA, Prior DL, Thamilarasan M, et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study. Am Heart J 2000; 140: 150-156. PMID: 10874278 721. Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007; 28: 1358-1365. PMID: 17350971 722. Feldman T, Young A. Percutaneous approaches to valve repair for mitral regurgitation. J Am Coll Cardiol 2014; 63: 2057-2068. PMID: 24583296 723. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: e57-185. PMID: 24603191 723a. Otto AM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143: e35-e71. PMID: 33332149 724. Feldman T, Foster E, Glower DD, et al. EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364: 1395-1406. PMID: 21463154 725. Stone GW, Lindenfeld J, Abraham WT, et al. COAPT Investigators. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. N Engl J Med 2018; 379: 2307-2318. PMID: 30280640 726. Obadia JF, Messika-Zeitoun D, Leurent G, et al. MITRA-FR Investigators. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation. N Engl J Med 2018; 379: 2297-2306. PMID: 30145927 727. Grayburn PA, Sannino A, Packer M. Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials. JACC Cardiovasc Imaging 2019; 12: 353-362. PMID: 30553663 728. Pibarot P, Delgado V, Bax JJ. MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results. Eur Heart J Cardiovasc Imaging 2019; 20: 620-624. PMID: 31115470 729. Feldman T, Kar S, Rinaldi M, et al. EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to- Edge REpair Study) cohort. J Am Coll Cardiol 2009; 54: 686-694. PMID: 19679246 730. 日本循環器学会.循環器病の診断と治療に関するガイドライン(2012年度合同研究班報告):ST上昇型急性心筋梗塞の診療に関するガイドライン(2013年改訂版).https://www.j-circ.or.jp/old/ guideline/pdf/JCS2013_kimura_h.pdf [2021年3月閲覧] 731. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: e362-e425. PMID: 23247304 732. Mitsui N, Koyama T, Marui A, et al. Experience with emergency cardiac surgery following institution of percutaneous cardiopulmonary support. Artif Organs 1999; 23: 496-499. PMID: 10392272 733. Ancona MB, Regazzoli D, Mangieri A, et al. Post-infarct ventricular septal rupture: early Impella implantation to delay surgery and reduce surgical risk. Cardiovasc Interv Ther 2017; 32: 381-385. PMID: 27604391 734. Crenshaw BS, Granger CB, Birnbaum Y, et al. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Risk factors, angiographic patterns, and out- comes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation 2000; 101: 27-32. PMID: 10618300 735. Prêtre R, Ye Q, Grünenfelder J, et al. Operative results of “repair” of ventricular septal rupture after acute myocardial infraction. Am J Cardiol 1999; 84: 785-788. PMID: 10513774 736. Topaz O, Taylor AL. Interventricular septal rupture complicating acute myocardial infarction: from pathophysiologic features to the role of invasive and noninvasive diagnostic modalities in current management. Am J Med 1992; 93: 683-688. PMID: 1466366 737. Papalexopoulou N, Young CP, Attia RQ. What is the best timing of surgery in patients with post-infarct ventricular septal rupture? Interact Cardiovasc Thorac Surg 2013; 16: 193-196. PMID: 23143273 738. Arnaoutakis GJ, Zhao Y, George TJ, et al. Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg 2012; 94: 436-443. PMID: 22626761 739. Menon V, Webb JG, Hillis LD, et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol 2000; 36: 1110-1116. PMID: 10985713 740. Holzer R, Balzer D, Amin Z, et al. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry. Catheter Cardiovasc Interv 2004; 61: 196-201. PMID: 14755811 741. Costache VS, Chavanon O, Bouvaist H, et al. Early Amplatzer occluder closure of a postinfarct ventricular septal defect as a bridge to surgical procedure. Interact Cardiovasc Thorac Surg 2007; 6: 503- 504. PMID: 17669918 742. Maltais S, Ibrahim R, Basmadjian AJ, et al. Postinfarction ventricular septal defects: towards a new treatment algorithm? Ann Thorac Surg 2009; 87: 687-692. PMID: 19231370 743. Yanagiuchi T, Tada N, Suchi T, et al. Spontaneous Resolution of Residual Shunting in 2 Compromised Patients after Amplatzer Occlusion of Postinfarction Ventricular Septal Defects. Tex Heart Inst J 2019; 46: 44-47. PMID: 30833838 744. Tada N, Takizawa K, Sakurai M, et al. Percutaneous closure of post-infarction ventricular septal defect using an Amplatzer septal occluder. Cardiovasc Interv Ther 2013; 28: 216-221. PMID: 23224935 745. Ishiyama M, Kurita T, Ishiura J, et al. Successful percutaneous treatment of recurrent post-infarction ventricular septal rupture using an Amplatzer duct occluder. J Cardiol Cases 2020; 21: 12-15. PMID: 31933699 746. Rihal CS, Sorajja P, Booker JD, et al. Principles of percutaneous paravalvular leak closure. JACC Cardiovasc Interv 2012; 5: 121- 130. PMID: 22361595 747. García E, Sandoval J, Unzue L, et al. Paravalvular leaks: mechanisms, diagnosis and management. EuroIntervention 2012; 8 Suppl: Q41-Q52. PMID: 22995111 748. Hourihan M, Perry SB, Mandell VS, et al. Transcatheter umbrella closure of valvular and paravalvular leaks. J Am Coll Cardiol 1992; 20: 1371-1377. PMID: 1385506 749. Sorajja P, Cabalka AK, Hagler DJ, et al. Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients. Circ Cardiovasc Interv 2011; 4: 314-321. PMID: 21791673 750. Calvert PA, Northridge DB, Malik IS, et al. Percutaneous Device Closure of Paravalvular Leak: Combined Experience From the United Kingdom and Ireland. Circulation 2016; 134: 934-944. PMID: 27587432 751. Onorato EM, Muratori M, Smolka G, et al. Midterm procedural and clinical outcomes of percutaneous paravalvular leak closure with the Occlutech Paravalvular Leak Device. EuroIntervention 2020; 15: 1251-1259. PMID: 31422926 752. Hara H, Matsumoto Y, Matsumoto T, et al. Percutaneous antegrade mitral paravalvular leak closure through porcelain atrial septumfirst percutaneous paravalvular leak closure in Japan. Circ J 2015; 79: 894-896. PMID: 25737016 753. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; 70: 252-289. PMID: 28315732 754. Ong K, Yu G, Jue J. Prevalence and spectrum of conditions associated with severe tricuspid regurgitation. Echocardiography 2014; 31: 558-562. PMID: 24304325